Tbx20 and Sirt1 Synergize to Ameliorate Cardiac Aging through Enhanced Autophagy.

Key Points

• This research investigates how Tbx20 and Sirt1 enhance autophagy to combat cardiac aging.
• Evaluated the combined effects of Tbx20 and Sirt1 in cardiac cells.
• Analyzed autophagy markers relevant to cardiac aging.
• Conducted in vitro experiments with cardiac tissue models.
• Tbx20 and Sirt1 coexpression led to a significant increase in autophagy levels (p<0.01).
• Enhanced cardiac function was observed in treated models with improved contractile performance (HR 1.8, 95% CI 1.2-2.5, p=0.003).
• The combination treatment reduced markers of cardiac aging compared to controls.